| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.2M | -61.9% |
| SG&A Expense | $9.9M | -27.2% |
| Operating Income | -$318.4M | -9475.5% |
| Pre-tax Income | -$324.0M | -3082.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$324.0M | -3346.0% |
| EPS (Basic) | -$8.72 | -2194.7% |
| EPS (Diluted) | -$8.72 | -2194.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -47.1% |
| Current Assets | $6.2M | +5598.0% |
| Total Assets | $6.8M | -97.6% |
| Current Liabilities | $13.0M | +236.2% |
| Total Liabilities | $159.9M | +1431.0% |
| Stockholders' Equity | -$153.0M | -1521.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.1M | -2557.4% |
| Capital Expenditures | $306K | +0.0% |
| Investing Cash Flow | -$306K | -176.1% |
| Financing Cash Flow | $40.5M | — |
| Free Cash Flow | -$26.4M | -1949.5% |